OPKO Health Announces Issuance of U.S. Patent Covering the Use and Administration of Certain Anti-VEGF siRNA's, Including Its Phase III Compound Bevasiranib Mar 18, 2008
OPKO Health and Pathogenics Announce Data Publication Demonstrating the Potential Utility of NCT in a Severe Eye Infection Feb 25, 2008
OPKO Health Acquires Rights to Innovative Ocular Product to Prevent Serious Eye Infections Oct 30, 2007
